Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles
- PMID: 25399693
- PMCID: PMC8029316
- DOI: 10.1111/bpa.12228
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles
Abstract
Melanotic tumors of the nervous system show overlapping histological characteristics but differ substantially in their biological behavior. In order to achieve a better delineation of such tumors, we performed an in-depth molecular characterization. Eighteen melanocytomas, 12 melanomas, and 14 melanotic and 14 conventional schwannomas (control group) were investigated for methylome patterns (450k array), gene mutations associated with melanotic tumors and copy number variants (CNVs). The methylome fingerprints assigned tumors to entity-specific groups. Methylation groups also showed a substantial overlap with histology-based diagnosis suggesting that they represent true biological entities. On the molecular level, melanotic schwannomas were characterized by a complex karyotype with recurrent monosomy of chromosome 22q and variable whole chromosomal gains and recurrent losses commonly involving chromosomes 1, 17p and 21. Melanocytomas carried GNAQ/11 mutations and presented with CNV involving chromosomes 3 and 6. Melanomas were frequently mutated in the TERT promoter, harbored additional oncogene mutations and showed recurrent chromosomal losses involving chromosomes 9, 10 and 6q, as well as gains of 22q. Together, melanotic nervous system tumors have several distinct mutational and chromosomal alterations and can reliably be distinguished by methylome profiling.
Keywords: 450k; GNA11; GNAQ; TERT promoter; copy number variants; melanocytoma; melanoma; melanotic schwannoma.
© 2014 International Society of Neuropathology.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".Am J Surg Pathol. 2014 Jan;38(1):94-105. doi: 10.1097/PAS.0b013e3182a0a150. Am J Surg Pathol. 2014. PMID: 24145644
-
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.J Neurooncol. 2016 May;127(3):435-44. doi: 10.1007/s11060-015-2052-2. Epub 2016 Jan 7. J Neurooncol. 2016. PMID: 26744134 Free PMC article.
-
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity.Brain Pathol. 2016 Mar;26(2):199-205. doi: 10.1111/bpa.12282. Epub 2015 Jul 30. Brain Pathol. 2016. PMID: 26113311 Free PMC article.
-
Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.Acta Neuropathol. 2010 Dec;120(6):755-64. doi: 10.1007/s00401-010-0749-z. Epub 2010 Sep 24. Acta Neuropathol. 2010. PMID: 20865267 Free PMC article. Review.
-
Melanotic Schwannoma of the Vulva: A Case Report and Review of the Literature.Am J Dermatopathol. 2020 Jan;42(1):46-51. doi: 10.1097/DAD.0000000000001482. Am J Dermatopathol. 2020. PMID: 31268928 Review.
Cited by
-
Primary Meningeal Melanocytic Tumors of the Central Nervous System: A Review from the Ultra-Rare Brain Tumors Task Force of the European Network for Rare Cancers (EURACAN).Cancers (Basel). 2024 Jul 10;16(14):2508. doi: 10.3390/cancers16142508. Cancers (Basel). 2024. PMID: 39061148 Free PMC article. Review.
-
[Histological and molecular characteristics of tumours of the peripheral nervous system].Pathologie (Heidelb). 2023 May;44(3):197-208. doi: 10.1007/s00292-023-01198-1. Epub 2023 Apr 28. Pathologie (Heidelb). 2023. PMID: 37115287 German.
-
Sporadic spinal psammomatous malignant melanotic nerve sheath tumor: A case report and literature review.Front Oncol. 2023 Feb 24;13:1100532. doi: 10.3389/fonc.2023.1100532. eCollection 2023. Front Oncol. 2023. PMID: 36910634 Free PMC article.
-
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.Neuro Oncol. 2023 Sep 5;25(9):1644-1655. doi: 10.1093/neuonc/noad053. Neuro Oncol. 2023. PMID: 36866403 Free PMC article.
-
Multiplatform molecular analysis of vestibular schwannoma reveals two robust subgroups with distinct microenvironment.J Neurooncol. 2023 Feb;161(3):491-499. doi: 10.1007/s11060-022-04221-2. Epub 2023 Jan 26. J Neurooncol. 2023. PMID: 36701029 Free PMC article.
References
-
- Bertola DR, Pereira AC, Brasil AC, Suzuki L, Leite C, Falzoni R et al (2012) Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship? Clin Genet 81:595–597. - PubMed
-
- Brat DJ, Giannini C, Scheithauer BW, Burger PC (1999) Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 23:745–754. - PubMed
-
- Bydon A, Gutierrez JA, Mahmood A (2003) Meningeal melanocytoma: an aggressive course for a benign tumor. J Neurooncol 64:259–263. - PubMed
-
- Carney JA (1990) Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol 14:206–222. - PubMed
-
- Egberts F, Bergner I, Kruger S, Haag J, Behrens HM, Hauschild A, Rocken C (2014) Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas. Ann Oncol 25:246–250. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical